Mice bearing simultaneous hindlimb and lung UPS tumors that received i.t. STING therapy all survived longer than control mice, with 30% of STING treated mice completely eradicating UPS tumors in both anatomic sites (Figure 3B). This evidence concerns the gene STING1 and undifferentiated pleomorphic sarcoma.